21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Combination of vaccination and inhibition of the PD-1 pathway
#2402Agent for use in the case of fructose intolerance
#2403Formulations for the treatment of disorders of the mouth, throat and respiratory tract
#2404Anticancer composition containing mixed herbal medicine extract as active ingredient
#2405Treatment for gastroesophageal reflux disease caused by a neurological disorder
#2406COMPOSITIONS AND METHODS FOR USING LAMELLAR BODIES FOR THERAPEUTIC PURPOSES
#2407USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR PROMOTING CHONDROCYTE GENERATION
#2408Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof
#2409COMBINATION THERAPY WITH A FLAVAGLINE AND 2-DEOXYGLUCOSE
#2410Synthetic composition and method for treating irritable bowel syndrome
#2411NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#2412COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER
#2413Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection
#2414Drug Combinations For the Treatment of HIV
#2415METHODS FOR TREATING CANCER
#2416Cancer Stem Cell Targeting Compounds
#2417PHARMACEUTICAL FORMULATIONS FOR TREATING GLAUCOMA AND METHODS FOR FABRICATING AND USING THEREOF
#2418Levocetirizine and montelukast in the treatment of inflammation mediated conditions
#2419ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#2420Methods of Administering Pirfenidone Therapy
#2421Treatment of debilitating fatigue
#2422COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA
#2423COMBINATION DRUG THERAPIES FOR CANCER AND METHODS OF MAKING AND USING THEM
#2424Oral use of zinc and copper gluconates in the treatment of digital dermatitis
#2425Cat appeasing pheromone
#2426Semiochemical compositions to reduce social conflicts with cats
#2427AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT
#2428Enteric soft capsules comprising polyunsaturated fatty acids
#2429Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
#2430USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#2431Dual assembly nanoparticles
#2432Treating infection by a platelet-targeting microbe using nanoparticles
#2433METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES
#2434Methods for treatment of metastatic thyroid cancer using a PDGFR-α inhibitor
#2435Micro-RNA family that modulates extracellular matrix genes and uses thereof
#2436GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy
#2437TETRACYCLIC AUTOTAXIN INHIBITORS
#2438Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#2439CANCER THERAPY TARGETING TETRASPANIN 33 (TSPAN33) IN MYELOID DERIVED SUPPRESSOR CELLS
#2440Method of diagnosing preeclampsia or pregnancy-induced hypertension
#2441Truncated von Willebrand factor polypeptides for treating hemophilia
#2442ANTIDIABETIC ORAL INSULIN BIGUANIDE COMBINATION
#2443TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#2444COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF
#2445Compositions and methods for treating cancer
#2446Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#2447NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#2448Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#2449NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#2450Arginase inhibitor combination therapies
#2451Vaginal inserted estradiol pharmaceutical compositions and methods
#2452Vaginal inserted estradiol pharmaceutical compositions and methods
#2453Vaginal inserted estradiol pharmaceutical compositions and methods
#2454Treatment of mitochondrial diseases
#2455Treatment of cancer and benign proliferative disorders
#2456PAC-1 combination therapy
#2457Methods for Treating Hyperuricemia and Related Diseases
#2458SYNTHETIC TRITERPENOIDS AND METHODS OF USE IN THE TREATMENT OF DISEASE
#2459Self-emulsifying formulations of DIM-related indoles
#2460Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof
#2461EQUINE SUPPLEMENT
#2462Methods and compositions for inhibition of ATR and FANCD2 activation
#2463Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use
#2464Composition and method for treating seizure disorders
#2465Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
#2466ETP derivatives
#2467Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#2468Cationic polymer coated mesoporous silica nanoparticles and uses thereof
#2469COMPOSITIONS AND METHODS FOR URINARY BLADDER REGENERATION
#2470Method of attacking target cells
#2471Methods of treatment with arginine deiminase
#2472Abuse-proof solid pharmaceutical composition
#2473DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES
#2474Process, tube and device for the preparation of wound healant composition
#2475COMPOSITIONS AND METHODS OF USING LAMELLAR BODIES FOR MODIFYING LINEAR BIOLOGICAL MACROMOLECULES
#2476Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
#2477Application of maltotriose-coated 4th generation poly(propyleneimine) dendrimer PPI-G4-OS-Mal-III
#2478Synergism of GOS and polyfructose
#2479Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
#2480RIBOFLAVIN FOR THE TREATMENT OF ISCHEMIC STROKE AND/OR OTHER GLUTAMATE EXCITOTOXICITY-ASSOCIATED DISEASES
#2481Methods of treating fibrosis
#2482MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES
#2483COMBINATION THERAPY WITH AXL INHIBITOR AND IMMUNE CHECKPOINT MODULATOR OR ONCOLYTIC VIRUS
#2484Oral solid formulation containing irinotecan and method of preparing the same
#2485Therapeutic targeting of myeloproliferative neoplasms by DUSP1 inhibition
#2486PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF
#2487BIPERIDEN FOR TREATING CANCER
#2488Treatment of sunburn using analgesics and antihistamines
#2489Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases
#2490METHODS OF TREATING SOLID TUMORS USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#2491Monoterpenes for treating respiratory diseases, in particular bronchopulmonary diseases
#2492MULTI-DRUG COMBINATIONS THAT ACT AS POTENT RADIOSENSITIZERS
#2493Anti-inflammatory omega-3 synergistic combinations
#2494THE COMPOSITIONS OF GLYCEROL AND /OR NON-TOXIC AMINO ACIDS FOR INHIBITING AND DESTROYING BIOFILM, INCLUDING RELATED METHODS
#2495Methods of treating pancreatic cancer
#2496Chemical reprogramming of human glial cells into neurons with small molecule cocktail
#2497COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER POSITIVE FOR EGFR MUTATION
#2498Endolysins Active Against Staphylococcus Bacteria, Pharmaceutical Compositions, and Methods Relating Thereto
#2499Treatment of Constipation-Predominant Irritable Bowel Syndrome
#2500Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof
#2501Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
#2502Enolase inhibitors and methods of treatment therewith
#2503Therapeutic Compositions
#2504TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE
#2505Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
#2506Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
#2507COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL
#2508Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease
#2509TRANS10:CIS12 ISOMER OF CONJUGATED LINOLEIC ACID AS A THERAPEUTIC AND PREVENTATIVE AGENT FOR HYPERTENSION SPECIFIC TO PREGNANCY
#2510METHODS FOR THE TREATMENT OF ROSACEA
#2511MULTIDRUG BRITTLE MATRIX COMPOSITIONS
#2512Astaxanthin anti-inflammatory synergistic combinations
#2513Therapeutic compositions comprising monoterpenes
#2514RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION
#2515ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#2516Use of Recombinant Human Activated Protein C to Enhance Viability of Transplant Tissue
#2517CXCL10 AS PREDICTIVE BIOMARKER OF RENAL TRANSPLANT ACUTE REJECTION AND DIAGNOSTIC BIOMARKER OF ANTIBODY-MEDIATED REJECTION (ABMR)
#2518Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy
#2519Acylated glucagon analogues
#2520Compounds and method for treating autoimmune diseases
#2521Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#2522Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor
#2523Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#2524Directed stem cell recruitment
#2525Rapid-acting insulin compositions
#2526Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
#2527ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS
#2528Composition comprising connective tissue growth factor (CTGF) for cardiac tissue repair
#2529Compositions, kits and methods for treating type II diabetes mellitus
#2530BACTERIAL POPULATIONS FOR PROMOTING HEALTH
#2531Enhancing the effect of car-engineered T cells by means of nucleic acid vaccination
#2532Nutritional supplement for growth enhancement
#2533Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#2534TOPICAL OPHTHALMIC FORMULATIONS FOR THE TREATMENT AND PREVENTION OF MIGRAINE HEADACHE
#2535Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders
#2536TREAMENT OF T-CELL MEDIATED DISEASES
#2537TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
#25385-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF
#2539MACROPINOCYTOSIS IN CANCER
#2540SACUBITRIL AND VALSARTAN FOR TREATING METABOLIC DISEASE
#2541COMPOSITIONS AND METHODS FOR THE TREATMENT OF SLEEP APNEA
#2542Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
#2543Combination comprising palmitoylethanolamide (PEA) and lycopene for use in the treatment of inflammatory diseases
#2544Two-layer separation-type eye drop containing squalane
#2545Aptamers against glioma cells
#2546Material and methods for treating or preventing HER-3 associated diseases
#2547Mito-honokiol compounds and methods of synthesis and use thereof
#2548Drug with antiviral activity (variants)
#2549Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use
#2550C-type natriuretic peptide agent for the treatment of alopecia
#2551Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
#2552COMPOSITIONS FOR A MEDICAL DEVICE COMPRISING EXOPOLYSACCHARIDE-PRODUCING BACTERIAL STRAINS IN ASSOCIATION WITH GUMS AND/OR GELATINES
#2553COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS
#2554NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#2555Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#2556Methods and compositions for treating and preventing viral infections
#2557ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
#2558BIHETEROARYL COMPOUNDS AND USES THEREOF
#2559FORMULATIONS, METHODS, KIT, AND DOSAGE FORMS FOR TREATING BACTERIAL INFECTION
#2560Pharmaceutical composition for treating cancer and a method of using the same
#2561COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
#2562METHODS OF TREATING LIVER DISEASE
#25632,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
#2564MONOACYLGLYCEROLS AND FAT-SOLUBLE NUTRIENTS FOR USE IN THE TREATMENT OF NUTRIENT DEFICIENCY FROM MALDIGESTION
#2565METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#2566Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
#2567DENDRITIC CELL IMMUNOTHERAPY
#2568Antimicrobial compositions and methods for locking catheters
#2569STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
#2570STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART
#2571STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
#2572Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
#2573METHOD OF TREATING NEOPLASIAS
#2574INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE
#2575Formulations for the treatment and prevention of obesity
#2576Methods of treating or preventing viral infection by using plant extracts
#2577METHODS AND COMPOSITIONS FOR BONE AND CARTILAGE REPAIR
#2578MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
#2579LINEAR POLYOL STABILIZED POLYFLUOROACRYLATE COMPOSITIONS
#2580Composition for treating tissue lesions
#2581Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells
#2582Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection
#2583COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
#2584Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects
#2585Compositions and methods for treatment of glioma
#2586Method of treating metabolic disorders and depression with dopamine receptor agonists
#2587KETOCONAZOLE ENANTIOMER IN HUMANS
#2588Method of inhibiting mutant C-KIT
#2589Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
#2590Combination therapies for treating cancer
#2591MICROBICIDAL COMPOSITION COMPRISING AN OCTOXYNOL AND A QUINOLIZIDINE ALKALOID COMPOUND OR A SOURCE THEREOF
#2592Sacubitril-valsartan dosage regimen for treating heart failure
#2593Methods and compositions for treating schizophrenia
#2594Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body
#2595Antitumoral use of cabazitaxel
#2596PROPHYLACTIC/THERAPEUTIC AGENT FOR VIRUS INFECTIONS WHICH COMPRISES ALA COMPOUND
#2597Synergistic famciclovir and celecoxib combination therapy for functional somatic syndromes
#2598THERAPY FOR LEUKEMIA
#2599MODULATION OF GEL TEMPERATURE OF POLOXAMER-CONTAINING FORMULATIONS
#2600COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS
#2601Matrix for receiving a tissue sample and use thereof
#2602Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#2603Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#2604DENDRITIC CELL INHIBITORY PROTEINS FROM TICKS
#2605Btk inhibitors
#2606Heteroaryls and uses thereof
#2607SK AND IK CHANNEL AGONISTS FOR TREATMENT OF HEART FAILURE
#2608Compounds for treatment of cancer
#2609PHARMACEUTICAL COMPOSITION CONTAINING A TRYPTOPHAN DERIVATIVE
#2610CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
#2611Method for the treatment of a solid tumour
#2612Abuse Deterrent Pharmaceutical Composition
#2613Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
#2614Cancer therapy with a parvovirus combined with a BCL-2 inhibitor
#2615Methods for combating bacterial infections by killing persister cells with mitomycin C and/or cisplatin
#2616Preparations for controlled-release of hypochlorous acid
#2617Composition and method to enhance expression of human defensin 2
#2618Therapy for malignant disease
#2619METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS
#2620Cationic polymers as co-drugs for chemotherapeutic agents
#2621Stabilized modified release vitamin D formulation and method of administering same
#2622COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE
#2623COMBINATION THERAPIES FOR TREATING CANCERS
#2624BIHETEROARYL COMPOUNDS AND USES THEREOF
#2625ORAL PHARMACEUTICAL COMPOSITION FOR INCREASING HYPOXIA TOLERANCE
#2626Combination therapy for cancer treatment
#2627Bromodomain and extra-terminal protein inhibitor combination therapy
#2628Targeting Metabolic Vulnerability in Triple-Negative Breast Cancer
#2629Compositions and methods for treating diseases of the nail
#2630USE OF NON-PEPTIDIC NK1 RECEPTOR ANTAGONISTS FOR THE PRODUCTION OF APOPTOSIS IN TUMOUR CELLS
#2631Treatment method by combined use of MDM2 inhibitor and BTK inhibitor
#2632Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening
#2633Targeting metabolic adaptive responses to chemotherapy
#2634ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF CANCER
#2635Treatment of pain with topical diclofenac
#2636Memantine combinations and use
#2637NOVEL TREATMENT OF PROSTATE CARCINOMA
#2638Stimulant abuse-deterrent compositions
#2639Methods for inducing cell division of postmitotic cells
#2640Compositions and methods for viral sensitization
#2641HIGH-THROUGHPUT IMAGE-BASED CHEMICAL SCREENING IN ZEBRAFISH BLASTOMERE CELL CULTURE
#2642Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#2643Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#2644Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#2645(R)-pirlindole and its pharmaceutically acceptable salts for use in medicine
#2646Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
#2647COMBINATIONS FOR THE TREATMENT OF CANCER
#2648ExPEC glycoconjugate vaccine formulations
#2649ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES
#2650Compositions containing a extract incubated with a filamentous fungus of the genus
#2651Bioassimilable protein-melanin complex, preparation and uses
#2652Cyclodextrin for the treatment of lysosomal storage diseases
#2653GLUTAMINE & TREHALOSE COMPOSITIONS
#26544,6-pyrimidinylene derivatives and uses thereof
#2655Compositions and methods for treating mitochondrial diseases
#2656METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS
#2657COMPOSITIONS AND METHODS FOR THE TREATMENTOF NEURODEGENERATIVE AND OTHER DISEASES
#2658COMPOSITIONS AND METHODS OF USING (R)-PRAMIPEXOLE
#2659Anthracycline prodrugs and methods of making and using the same
#2660Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer
#2661Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms
#2662Gel capsule containing sterol and solubilising agent
#2663Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#2664N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
#2665Cyclic vinylogous amides as bromodomain inhibitors
#2666Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#2667Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
#2668Pharmaceutical formulations containing lipoic acid derivatives
#2669Compositions and methods for the treatment or the prevention of infections and for the eradication or reduction of surfaces
#2670GLUCAGON RECEPTOR AGONISTS
#2671Formulations for the treatment of mucosal lesions
#2672USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATIATION AGENT FOR THE TREATMENT OF OBESITY
#2673COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
#2674Methods and compositions for extending lifespan
#2675COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES ASSOCIATED WITH ACTIVATED T CELLS AND/OR B CELLS
#2676METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION
#2677Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#2678TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY
#2679TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY
#2680(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use
#2681TRANSDERMAL CONTRACEPTIVE HORMONES DELIVERY
#2682PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
#2683Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
#2684Dry powder formulation of azole derivative for inhalation
#2685METHODS OF TREATMENT COMPRISING ADMINISTERING A HIGH DAILY DOSE OF OXYCODONE AND NALOXONE IN A 2:1 WEIGHT RATIO
#2686Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers
#2687Bowel cleansing composition
#2688Prevention of psychotic disorders and/or treatment of psychotic symptoms
#2689Antimicrobials and methods of use thereof for wound healing
#2690Transdermal Delivery
#2691THERMO-SENSITIVE BONE GROWTH COMPOSITIONS
#2692Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#2693Organic compositions to treat EPAS1-related diseases
#2694DIABETES TREATMENT
#2695Compositions and Methods for Managing Weight
#2696USE OF ALGINATE COMPOSITIONS IN PREVENTING OR REDUCING LIVER DAMAGE CAUSED BY A HEPATOTOXIC AGENT
#2697Tumor-selective combination therapy
#2698DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF
#2699Compositions for improving cell viability and methods of use thereof
#2700Combination Products with Tyrosine Kinase Inhibitors and their Use